Navigation Links
Van Andel Institute and Children's Memorial Research Center of Chicago Form a Partnership to Facilitate Pediatric Research
Date:2/26/2008

XenoBase software can be used to develop more effective treatments for pediatric patients

GRAND RAPIDS, Mich., Feb. 26 /PRNewswire-USNewswire/ -- Van Andel Institute (VAI) has entered into a multi-year licensing agreement with Children's Memorial Research Center (CMRC) of Chicago for use of its XenoBase software and database system.

XenoBase is a unique, advanced bio-informatic system created by scientists at Van Andel Research Institute (VARI) to support all aspects of the life sciences from basic research discovery to clinical application. The platform holds great promise for researchers and clinicians who use the system to explore the molecular and clinical basis of disease. In recent applications, physicians have used the tool to match the molecular profile of tumors of late-stage cancer patients to the most effective therapy, based on molecular evidence.

"The XenoBase technology holds great promise for the future as we evolve toward a more proactive standard of health care," said VAI Chairman & CEO David Van Andel. "We are pleased to enter into this agreement with an internationally recognized research center under the fine leadership of Dr. Hendrix who is dedicated to producing innovative solutions to prevent, diagnose and treat diseases affecting children."

CMRC is the research arm of Children's Memorial Hospital (CMH), the pediatric teaching hospital for Northwestern University's Feinberg School of Medicine. It is one of only a handful of institutions in the United States dedicated exclusively to pediatric research. Like the researchers at VARI, the research team of CMRC will use XenoBase to explore the molecular and clinical basis for disease and to support the discovery of novel approaches to alleviate pain and suffering due to disease.

"As a result of this agreement between CMRC and VARI, we anticipate novel collaborations using XenoBase to more quickly impact human disease," said Mary J.C. Hendrix, Ph.D
'/>"/>

SOURCE Children's Memorial Hospital
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. OHSU Cancer Institute research gives hope for chemo holidays for men with advanced prostate cancer
2. Otho S.A. Sprague Memorial Institute awards Rush nearly $125,000 for new patient-safety project
3. Otho S.A. Sprague Memorial Institute awards Rush $230,000 for childhood obesity prevention
4. Bishop T. D. Jakes Receives The Black Aids Institute 2008 Heroes in the Struggle Award
5. UNT Health Science Center and The Center for Cancer and Blood Disorders Collaborate on New Institute for Cancer and Blood Disorders
6. China Holdings Announces Starwood Research Institute Initiates Research Coverage
7. OHSU cancer institute researcher discovers new predictor of prostate cancer recurrence
8. Southern Research Institute Names Blaine Knight Vice President of Drug Discovery
9. VEGF Neutralization Can Damage Brain Vessels, Say Schepens Eye Research Institute Scientists
10. VEGF neutralization can damage brain vessels, say Schepens Eye Research Institute scientists
11. Dana-Farber Cancer Institute Completes Deployment of MedAptus Infusion Services Module
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... Hope For The Warriors® is excited to ... staff. This addition comes in tandem with new office ... The Warriors® is a national nonprofit organization that assists ... the fallen who have sustained physical and psychological wounds ... will support programs within Career Transition & Education. He ...
(Date:7/22/2014)... Garland’s new Energizer BK ... used as a flood coat over new and existing ... premium restoration material. It provides natural resistance to moisture, ... reducing life-cycle costs. Energizer BK is specially formulated with ... resistance in addition to superior strength and flexibility. ...
(Date:7/22/2014)... July 22, 2014 The hair ... are now offering robotic assisted laser therapy and ... solutions for men and women suffering from hair ... they now offer Follicular Unit Extraction (FUE) procedures ... robot. With this new technology, their doctors use ...
(Date:7/21/2014)... fastest-growing high school sports in the United States, with ... game. The growing participation numbers, however, mean that more ... in lacrosse practice and competition. , In a study ... Sports Medicine and available in an upcoming print ... Policy at Nationwide Children,s Hospital and the Colorado School ...
(Date:7/21/2014)... As reported by CBS Local Pittsburgh in the article ... (7/15), thrill-seeking participants raised $100,000 to raise drug abuse ... Philly. 100 people, including some well-known local news reporters, ... Hotel. Some of the participants shared stories of their ... son killed himself after a long battle with addiction. ...
Breaking Medicine News(10 mins):Health News:Hope For The Warriors Builds on Staff and Office Space in Chicago to Support Career Transition for Vets 2Health News:Energizer® BK Waterproof Coating from Garland Canada Reduces Life-Cycle Costs 2Health News:WeGrowHair.com/PAI Medical Group Introduces Robotic Assisted Laser Therapy to Treat Hair Loss 2Health News:New study finds high school lacrosse players at risk for concussions, other injuries 2Health News:New study finds high school lacrosse players at risk for concussions, other injuries 3Health News:100 People Climb Down Building to Raise Drug Addiction Awareness in Philadelphia 2Health News:100 People Climb Down Building to Raise Drug Addiction Awareness in Philadelphia 3
... --MinuteClinic Provides Quality and Convenience Close to Home and the ... ... Alliance With Integris Health--, OKLAHOMA CITY, Sept. 7 Quick, convenient, ... opening of a,MinuteClinic health care center at the CVS/pharmacy store in Moore ...
... pulmonary embolisma potential life-threatening blockage in a lung arteryshould ... than a CT (computed tomography) angiogram, conclude authors in ... Medicine. , A V/Q scan can be the first ... a pulmonary embolism, noted H. Dirk Sostman, a professor ...
... School at the University of Warwick reveals that womens health ... , The researchers looked at men and women sleeping ... see if their risk of having hypertension was any higher ... more of sleep a night. Among other problems increased hypertension ...
... Blue Shield in Indiana for its Members, INDIANAPOLIS, ... and,M-Plan, Inc., an Indiana-based managed care organization, announced today,that ... of Indiana as,the insurer of choice for its members ... WellPoint and M-Plan have entered into an,agreement that ensures ...
... KING OF PRUSSIA, PA, Sept. 7 /PRNewswire-FirstCall/ - ... discovery and development,solutions, has won the Good Clinical ... that best promotes access to new medicines. This,award ... awards introduced this year to,recognize excellence in clinical ...
... N.J., Sept. 6 Wyeth (NYSE: WYE ... that the United States,District Court for the District ... a preliminary injunction against Teva Pharmaceuticals USA, Inc.,and ... of a generic,version of PROTONIX(R) (pantoprazole sodium) prior ...
Cached Medicine News:Health News:An Innovation in Health Care Opens at a CVS/pharmacy Store in the Oklahoma City Region 2Health News:An Innovation in Health Care Opens at a CVS/pharmacy Store in the Oklahoma City Region 3Health News:An Innovation in Health Care Opens at a CVS/pharmacy Store in the Oklahoma City Region 4Health News:An Innovation in Health Care Opens at a CVS/pharmacy Store in the Oklahoma City Region 5Health News:Nuclear medicine approach can be first choice for excluding pulmonary embolism in young women 2Health News:WellPoint and M-Plan Enter Into Endorsement Agreement as M-Plan Announces Exit From the Commercial HMO Business in Indiana 2Health News:WellPoint and M-Plan Enter Into Endorsement Agreement as M-Plan Announces Exit From the Commercial HMO Business in Indiana 3Health News:MDS Pharma Services Wins Award for Management of Global Malaria Trial 2Health News:Wyeth and Nycomed Announce Court Denial of Preliminary Injunction 2Health News:Wyeth and Nycomed Announce Court Denial of Preliminary Injunction 3
(Date:7/21/2014)... , July 21, 2014 Decision Resources ... (AD) therapies will more than triple, reaching nearly ... forecasted launch of the first disease-modifying therapies (DMTs), ... these novel premium-priced agents—which include the anti-beta-amyloid monoclonal ... well as the BACE inhibitor MK-8931 (Roche/Chugai/MorphoSys)—will earn ...
(Date:7/21/2014)... ALBANY, New York , July 21, 2014 /PRNewswire/ ... market report published by Transparency Market Research "E-Clinical Solution ... and Forecast, 2014 - 2020," the global microfluidic device ... and is expected to grow at a CAGR of ... value of USD 6,515.3 million in 2020. ...
(Date:7/21/2014)...  PowerVision, Inc., a medical device company developing ... announced that Douglas D. Koch , M.D., ... and Professor of Ophthalmology, at Baylor College of ... As a recipient of several ... Lifetime Achievement award, Koch will join the distinguished ...
Breaking Medicine Technology:The Alzheimer's Disease Market Is Forecast to Reach Nearly $12 Billion by 2023, Following the Projected Launch of the First Disease-Modifying Therapies 2The Alzheimer's Disease Market Is Forecast to Reach Nearly $12 Billion by 2023, Following the Projected Launch of the First Disease-Modifying Therapies 3E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 2E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 3E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 4E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 5PowerVision Appoints Ophthalmology Thought Leader Douglas D. Koch, M.D. to its Scientific Advisory Board 2PowerVision Appoints Ophthalmology Thought Leader Douglas D. Koch, M.D. to its Scientific Advisory Board 3PowerVision Appoints Ophthalmology Thought Leader Douglas D. Koch, M.D. to its Scientific Advisory Board 4
... 13, 2011  GeoVax Labs, Inc. (OTCQB/OTCBB: GOVX), an Atlanta-based ... fight Human Immunodeficiency Virus (HIV) infections, announced that the ... clinical trial for the Company,s HIV/AIDS therapeutic vaccine.  This ... the treatment of persons who are HIV infected. ...
... Masimo (NASDAQ: MASI ) ... Acoustic Respiration Rate (RRa™) was presented at the ... Graduate Assembly (PGA) Meeting in New York City. ... the positive clinical outcomes and patient safety impact of Masimo,s ...
Cached Medicine Technology:GeoVax Labs' First Patient Inoculated in Phase 1/2 Clinical Trial for HIV/AIDS Therapeutic Vaccine 2GeoVax Labs' First Patient Inoculated in Phase 1/2 Clinical Trial for HIV/AIDS Therapeutic Vaccine 3New Clinical Study Presented at the NYPGA Meeting Shows Respiration Rate Monitoring -- Considered the Fourth Primary Vital Sign -- Has Been Revolutionized With Masimo rainbow Acoustic Monitoring Technology 2New Clinical Study Presented at the NYPGA Meeting Shows Respiration Rate Monitoring -- Considered the Fourth Primary Vital Sign -- Has Been Revolutionized With Masimo rainbow Acoustic Monitoring Technology 3New Clinical Study Presented at the NYPGA Meeting Shows Respiration Rate Monitoring -- Considered the Fourth Primary Vital Sign -- Has Been Revolutionized With Masimo rainbow Acoustic Monitoring Technology 4New Clinical Study Presented at the NYPGA Meeting Shows Respiration Rate Monitoring -- Considered the Fourth Primary Vital Sign -- Has Been Revolutionized With Masimo rainbow Acoustic Monitoring Technology 5
... At the heart of the innovative ... EU-M60, delivering excellent imaging performance to meet ... Together with the new GF-UM160 ultrasonic gastrovideoscope, ... penetration to view organs deeper in the ...
There are many reasons to choose the CardioGenesis 2000 Holmium:YAG Laser System for TMR in your hospital or medical facility. Among the first is the CardioGenesis commitment to deliver the highest q...
Ultrasensitive TSH EIA Thyroid Function 025-BC-1003...
Total T3 EIA Thyroid Function 025-BC-1005...
Medicine Products: